
Resources
Guides, research, and perspectives on R&D intelligence, IP strategy, and the future of AI enabled innovation.

Executive Summary
In 2024, US patent infringement jury verdicts totaled $4.19 billion across 72 cases. Twelve individual verdicts exceeded $100million. The largest single award—$857 million in General Access Solutions v.Cellco Partnership (Verizon)—exceeded the annual R&D budget of many mid-market technology companies. In the first half of 2025 alone, total damages reached an additional $1.91 billion.
The consequences of incomplete patent intelligence are not abstract. In what has become one of the most instructive IP disputes in recent history, Masimo’s pulse oximetry patents triggered a US import ban on certain Apple Watch models, forcing Apple to disable its blood oxygen feature across an entire product line, halt domestic sales of affected models, invest in a hardware redesign, and ultimately face a $634 million jury verdict in November 2025. Apple—a company with one of the most sophisticated intellectual property organizations on earth—spent years in litigation over technology it might have designed around during development.
For organizations with fewer resources than Apple, the risk calculus is starker. A mid-size materials company, a university spinout, or a defense contractor developing next-generation battery technology cannot absorb a nine-figure verdict or a multi-year injunction. For these organizations, the patent landscape analysis conducted during the development phase is the primary risk mitigation mechanism. The quality of that analysis is not a matter of convenience. It is a matter of survival.
And yet, a growing number of R&D and IP teams are conducting that analysis using general-purpose AI tools—ChatGPT, Claude, Microsoft Co-Pilot—that were never designed for patent intelligence and are structurally incapable of delivering it.
This report presents the findings of a controlled comparison study in which identical patent landscape queries were submitted to four AI-powered tools: Cypris (a purpose-built R&D intelligence platform),ChatGPT (OpenAI), Claude (Anthropic), and Microsoft Co-Pilot. Two technology domains were tested: solid-state lithium-sulfur battery electrolytes using garnet-type LLZO ceramic materials (freedom-to-operate analysis), and bio-based polyamide synthesis from castor oil derivatives (competitive intelligence).
The results reveal a significant and structurally persistent gap. In Test 1, Cypris identified over 40 active US patents and published applications with granular FTO risk assessments. Claude identified 12. ChatGPT identified 7, several with fabricated attribution. Co-Pilot identified 4. Among the patents surfaced exclusively by Cypris were filings rated as “Very High” FTO risk that directly claim the technology architecture described in the query. In Test 2, Cypris cited over 100 individual patent filings with full attribution to substantiate its competitive landscape rankings. No general-purpose model cited a single patent number.
The most active sectors for patent enforcement—semiconductors, AI, biopharma, and advanced materials—are the same sectors where R&D teams are most likely to adopt AI tools for intelligence workflows. The findings of this report have direct implications for any organization using general-purpose AI to inform patent strategy, competitive intelligence, or R&D investment decisions.

1. Methodology
A single patent landscape query was submitted verbatim to each tool on March 27, 2026. No follow-up prompts, clarifications, or iterative refinements were provided. Each tool received one opportunity to respond, mirroring the workflow of a practitioner running an initial landscape scan.
1.1 Query
Identify all active US patents and published applications filed in the last 5 years related to solid-state lithium-sulfur battery electrolytes using garnet-type ceramic materials. For each, provide the assignee, filing date, key claims, and current legal status. Highlight any patents that could pose freedom-to-operate risks for a company developing a Li₇La₃Zr₂O₁₂(LLZO)-based composite electrolyte with a polymer interlayer.
1.2 Tools Evaluated

1.3 Evaluation Criteria
Each response was assessed across six dimensions: (1) number of relevant patents identified, (2) accuracy of assignee attribution,(3) completeness of filing metadata (dates, legal status), (4) depth of claim analysis relative to the proposed technology, (5) quality of FTO risk stratification, and (6) presence of actionable design-around or strategic guidance.
2. Findings
2.1 Coverage Gap
The most significant finding is the scale of the coverage differential. Cypris identified over 40 active US patents and published applications spanning LLZO-polymer composite electrolytes, garnet interface modification, polymer interlayer architectures, lithium-sulfur specific filings, and adjacent ceramic composite patents. The results were organized by technology category with per-patent FTO risk ratings.
Claude identified 12 patents organized in a four-tier risk framework. Its analysis was structurally sound and correctly flagged the two highest-risk filings (Solid Energies US 11,967,678 and the LLZO nanofiber multilayer US 11,923,501). It also identified the University ofMaryland/ Wachsman portfolio as a concentration risk and noted the NASA SABERS portfolio as a licensing opportunity. However, it missed the majority of the landscape, including the entire Corning portfolio, GM's interlayer patents, theKorea Institute of Energy Research three-layer architecture, and the HonHai/SolidEdge lithium-sulfur specific filing.
ChatGPT identified 7 patents, but the quality of attribution was inconsistent. It listed assignees as "Likely DOE /national lab ecosystem" and "Likely startup / defense contractor cluster" for two filings—language that indicates the model was inferring rather than retrieving assignee data. In a freedom-to-operate context, an unverified assignee attribution is functionally equivalent to no attribution, as it cannot support a licensing inquiry or risk assessment.
Co-Pilot identified 4 US patents. Its output was the most limited in scope, missing the Solid Energies portfolio entirely, theUMD/ Wachsman portfolio, Gelion/ Johnson Matthey, NASA SABERS, and all Li-S specific LLZO filings.
2.2 Critical Patents Missed by Public Models
The following table presents patents identified exclusively by Cypris that were rated as High or Very High FTO risk for the proposed technology architecture. None were surfaced by any general-purpose model.

2.3 Patent Fencing: The Solid Energies Portfolio
Cypris identified a coordinated patent fencing strategy by Solid Energies, Inc. that no general-purpose model detected at scale. Solid Energies holds at least four granted US patents and one published application covering LLZO-polymer composite electrolytes across compositions(US-12463245-B2), gradient architectures (US-12283655-B2), electrode integration (US-12463249-B2), and manufacturing processes (US-20230035720-A1). Claude identified one Solid Energies patent (US 11,967,678) and correctly rated it as the highest-priority FTO concern but did not surface the broader portfolio. ChatGPT and Co-Pilot identified zero Solid Energies filings.
The practical significance is that a company relying on any individual patent hit would underestimate the scope of Solid Energies' IP position. The fencing strategy—covering the composition, the architecture, the electrode integration, and the manufacturing method—means that identifying a single design-around for one patent does not resolve the FTO exposure from the portfolio as a whole. This is the kind of strategic insight that requires seeing the full picture, which no general-purpose model delivered
2.4 Assignee Attribution Quality
ChatGPT's response included at least two instances of fabricated or unverifiable assignee attributions. For US 11,367,895 B1, the listed assignee was "Likely startup / defense contractor cluster." For US 2021/0202983 A1, the assignee was described as "Likely DOE / national lab ecosystem." In both cases, the model appears to have inferred the assignee from contextual patterns in its training data rather than retrieving the information from patent records.
In any operational IP workflow, assignee identity is foundational. It determines licensing strategy, litigation risk, and competitive positioning. A fabricated assignee is more dangerous than a missing one because it creates an illusion of completeness that discourages further investigation. An R&D team receiving this output might reasonably conclude that the landscape analysis is finished when it is not.
3. Structural Limitations of General-Purpose Models for Patent Intelligence
3.1 Training Data Is Not Patent Data
Large language models are trained on web-scraped text. Their knowledge of the patent record is derived from whatever fragments appeared in their training corpus: blog posts mentioning filings, news articles about litigation, snippets of Google Patents pages that were crawlable at the time of data collection. They do not have systematic, structured access to the USPTO database. They cannot query patent classification codes, parse claim language against a specific technology architecture, or verify whether a patent has been assigned, abandoned, or subjected to terminal disclaimer since their training data was collected.
This is not a limitation that improves with scale. A larger training corpus does not produce systematic patent coverage; it produces a larger but still arbitrary sampling of the patent record. The result is that general-purpose models will consistently surface well-known patents from heavily discussed assignees (QuantumScape, for example, appeared in most responses) while missing commercially significant filings from less publicly visible entities (Solid Energies, Korea Institute of EnergyResearch, Shenzhen Solid Advanced Materials).
3.2 The Web Is Closing to Model Scrapers
The data access problem is structural and worsening. As of mid-2025, Cloudflare reported that among the top 10,000 web domains, the majority now fully disallow AI crawlers such as GPTBot andClaudeBot via robots.txt. The trend has accelerated from partial restrictions to outright blocks, and the crawl-to-referral ratios reveal the underlying tension: OpenAI's crawlers access approximately1,700 pages for every referral they return to publishers; Anthropic's ratio exceeds 73,000 to 1.
Patent databases, scientific publishers, and IP analytics platforms are among the most restrictive content categories. A Duke University study in 2025 found that several categories of AI-related crawlers never request robots.txt files at all. The practical consequence is that the knowledge gap between what a general-purpose model "knows" about the patent landscape and what actually exists in the patent record is widening with each training cycle. A landscape query that a general-purpose model partially answered in 2023 may return less useful information in 2026.
3.3 General-Purpose Models Lack Ontological Frameworks for Patent Analysis
A freedom-to-operate analysis is not a summarization task. It requires understanding claim scope, prosecution history, continuation and divisional chains, assignee normalization (a single company may appear under multiple entity names across patent records), priority dates versus filing dates versus publication dates, and the relationship between dependent and independent claims. It requires mapping the specific technical features of a proposed product against independent claim language—not keyword matching.
General-purpose models do not have these frameworks. They pattern-match against training data and produce outputs that adopt the format and tone of patent analysis without the underlying data infrastructure. The format is correct. The confidence is high. The coverage is incomplete in ways that are not visible to the user.
4. Comparative Output Quality
The following table summarizes the qualitative characteristics of each tool's response across the dimensions most relevant to an operational IP workflow.

5. Implications for R&D and IP Organizations
5.1 The Confidence Problem
The central risk identified by this study is not that general-purpose models produce bad outputs—it is that they produce incomplete outputs with high confidence. Each model delivered its results in a professional format with structured analysis, risk ratings, and strategic recommendations. At no point did any model indicate the boundaries of its knowledge or flag that its results represented a fraction of the available patent record. A practitioner receiving one of these outputs would have no signal that the analysis was incomplete unless they independently validated it against a comprehensive datasource.
This creates an asymmetric risk profile: the better the format and tone of the output, the less likely the user is to question its completeness. In a corporate environment where AI outputs are increasingly treated as first-pass analysis, this dynamic incentivizes under-investigation at precisely the moment when thoroughness is most critical.
5.2 The Diversification Illusion
It might be assumed that running the same query through multiple general-purpose models provides validation through diversity of sources. This study suggests otherwise. While the four tools returned different subsets of patents, all operated under the same structural constraints: training data rather than live patent databases, web-scraped content rather than structured IP records, and general-purpose reasoning rather than patent-specific ontological frameworks. Running the same query through three constrained tools does not produce triangulation; it produces three partial views of the same incomplete picture.
5.3 The Appropriate Use Boundary
General-purpose language models are effective tools for a wide range of tasks: drafting communications, summarizing documents, generating code, and exploratory research. The finding of this study is not that these tools lack value but that their value boundary does not extend to decisions that carry existential commercial risk.
Patent landscape analysis, freedom-to-operate assessment, and competitive intelligence that informs R&D investment decisions fall outside that boundary. These are workflows where the completeness and verifiability of the underlying data are not merely desirable but are the primary determinant of whether the analysis has value. A patent landscape that captures 10% of the relevant filings, regardless of how well-formatted or confidently presented, is a liability rather than an asset.
6. Test 2: Competitive Intelligence — Bio-Based Polyamide Patent Landscape
To assess whether the findings from Test 1 were specific to a single technology domain or reflected a broader structural pattern, a second query was submitted to all four tools. This query shifted from freedom-to-operate analysis to competitive intelligence, asking each tool to identify the top 10organizations by patent filing volume in bio-based polyamide synthesis from castor oil derivatives over the past three years, with summaries of technical approach, co-assignee relationships, and portfolio trajectory.
6.1 Query

6.2 Summary of Results

6.3 Key Differentiators
Verifiability
The most consequential difference in Test 2 was the presence or absence of verifiable evidence. Cypris cited over 100 individual patent filings with full patent numbers, assignee names, and publication dates. Every claim about an organization’s technical focus, co-assignee relationships, and filing trajectory was anchored to specific documents that a practitioner could independently verify in USPTO, Espacenet, or WIPO PATENT SCOPE. No general-purpose model cited a single patent number. Claude produced the most structured and analytically useful output among the public models, with estimated filing ranges, product names, and strategic observations that were directionally plausible. However, without underlying patent citations, every claim in the response requires independent verification before it can inform a business decision. ChatGPT and Co-Pilot offered thinner profiles with no filing counts and no patent-level specificity.
Data Integrity
ChatGPT’s response contained a structural error that would mislead a practitioner: it listed CathayBiotech as organization #5 and then listed “Cathay Affiliate Cluster” as a separate organization at #9, effectively double-counting a single entity. It repeated this pattern with Toray at #4 and “Toray(Additional Programs)” at #10. In a competitive intelligence context where the ranking itself is the deliverable, this kind of error distorts the landscape and could lead to misallocation of competitive monitoring resources.
Organizations Missed
Cypris identified Kingfa Sci. & Tech. (8–10 filings with a differentiated furan diacid-based polyamide platform) and Zhejiang NHU (4–6 filings focused on continuous polymerization process technology)as emerging players that no general-purpose model surfaced. Both represent potential competitive threats or partnership opportunities that would be invisible to a team relying on public AI tools.Conversely, ChatGPT included organizations such as ANTA and Jiangsu Taiji that appear to be downstream users rather than significant patent filers in synthesis, suggesting the model was conflating commercial activity with IP activity.
Strategic Depth
Cypris’s cross-cutting observations identified a fundamental chemistry divergence in the landscape:European incumbents (Arkema, Evonik, EMS) rely on traditional castor oil pyrolysis to 11-aminoundecanoic acid or sebacic acid, while Chinese entrants (Cathay Biotech, Kingfa) are developing alternative bio-based routes through fermentation and furandicarboxylic acid chemistry.This represents a potential long-term disruption to the castor oil supply chain dependency thatWestern players have built their IP strategies around. Claude identified a similar theme at a higher level of abstraction. Neither ChatGPT nor Co-Pilot noted the divergence.
6.4 Test 2 Conclusion
Test 2 confirms that the coverage and verifiability gaps observed in Test 1 are not domain-specific.In a competitive intelligence context—where the deliverable is a ranked landscape of organizationalIP activity—the same structural limitations apply. General-purpose models can produce plausible-looking top-10 lists with reasonable organizational names, but they cannot anchor those lists to verifiable patent data, they cannot provide precise filing volumes, and they cannot identify emerging players whose patent activity is visible in structured databases but absent from the web-scraped content that general-purpose models rely on.
7. Conclusion
This comparative analysis, spanning two distinct technology domains and two distinct analytical workflows—freedom-to-operate assessment and competitive intelligence—demonstrates that the gap between purpose-built R&D intelligence platforms and general-purpose language models is not marginal, not domain-specific, and not transient. It is structural and consequential.
In Test 1 (LLZO garnet electrolytes for Li-S batteries), the purpose-built platform identified more than three times as many patents as the best-performing general-purpose model and ten times as many as the lowest-performing one. Among the patents identified exclusively by the purpose-built platform were filings rated as Very High FTO risk that directly claim the proposed technology architecture. InTest 2 (bio-based polyamide competitive landscape), the purpose-built platform cited over 100individual patent filings to substantiate its organizational rankings; no general-purpose model cited as ingle patent number.
The structural drivers of this gap—reliance on training data rather than live patent feeds, the accelerating closure of web content to AI scrapers, and the absence of patent-specific analytical frameworks—are not transient. They are inherent to the architecture of general-purpose models and will persist regardless of increases in model capability or training data volume.
For R&D and IP leaders, the practical implication is clear: general-purpose AI tools should be used for general-purpose tasks. Patent intelligence, competitive landscaping, and freedom-to-operate analysis require purpose-built systems with direct access to structured patent data, domain-specific analytical frameworks, and the ability to surface what a general-purpose model cannot—not because it chooses not to, but because it structurally cannot access the data.
The question for every organization making R&D investment decisions today is whether the tools informing those decisions have access to the evidence base those decisions require. This study suggests that for the majority of general-purpose AI tools currently in use, the answer is no.
About This Report
This report was produced by Cypris (IP Web, Inc.), an AI-powered R&D intelligence platform serving corporate innovation, IP, and R&D teams at organizations including NASA, Johnson & Johnson, theUS Air Force, and Los Alamos National Laboratory. Cypris aggregates over 500 million data points from patents, scientific literature, grants, corporate filings, and news to deliver structured intelligence for technology scouting, competitive analysis, and IP strategy.
The comparative tests described in this report were conducted on March 27, 2026. All outputs are preserved in their original form. Patent data cited from the Cypris reports has been verified against USPTO Patent Center and WIPO PATENT SCOPE records as of the same date. To conduct a similar analysis for your technology domain, contact info@cypris.ai or visit cypris.ai.
The Patent Intelligence Gap - A Comparative Analysis of Verticalized AI-Patent Tools vs. General-Purpose Language Models for R&D Decision-Making
Blogs


There are 631+ commercial entities operating in the nuclear energy space based on IP ownership or if they’ve referenced the key terms in market news, about us pages, or SEC filings. Across the board, China takes the lead.
Over the past year, the most active commercial entities IP filing were SHANGHAI NUCLEAR ENG RES & DESIGN INST CO LTD, BEIJING INSTITUTE TECH, and CHINA NUCLEAR POWER ENG CO LTD.


Among patents filed by the most active entity, SHANGHAI NUCLEAR ENG RES & DESIGN INST CO LTD, were those focused on:
– Nuclear energy steam supply system
– Dual-purpose transportation container for uranium dioxide pellet powder
– Sewage discharging and heat supplying system of steam generator of nuclear power station


China accounts for 518 patent applicants (67.9% of patent applicant activity), followed by Russia and the World Intellectual Property Organization.
For actionable innovation intelligence in your industry, visit ipcypris.com. To browse recent patent filings for free, explore our our global patent search engine.

Why invest in R&D? Research and development is essential for organizations looking to stay competitive and innovate. Despite the potential rewards of investing in R&D, there are several challenges that must be considered before diving into a project.
Understanding these challenges as well as how to overcome them with strategies can help ensure success when investing in R&D.
Cypris offers an efficient platform designed specifically for teams engaged in R&D and innovation projects, helping reduce time-to-insight while ensuring successful investments into new ideas or processes.
Read on to learn more about the benefits, challenges, and strategies of why invest in R&D with Cypris!
Table of Contents
Challenges of Investing in R&D
Why Invest in R&D With Cypris?
What is R&D and why is it important?
Should I invest in research and development?
Why is R&D important for innovation?
What is R&D?
R&D is an important part of any company’s operations. It helps to create new products and services, as well as improve existing ones.
However, it can be difficult to measure the return on investment (ROI) for R&D expenses due to their long-term nature and uncertain outcomes.
One way that companies have tried to maximize the ROI from their R&D investments is by implementing a “20% rule” which allows employees to spend 20% of their time working on personal projects related to the company’s core business objectives.
Alphabet Inc. has been particularly successful with this approach. Many popular products such as Gmail and Wear OS were created through its 20% rule initiative.
Another strategy for maximizing ROI from R&D involves setting clear goals before beginning research activities.
Companies should determine what they want out of their research efforts in terms of tangible results or improvements in existing products or services before investing resources into them.
This will help ensure that funds are being spent wisely and efficiently towards achieving desired outcomes rather than wasted on unproductive pursuits.
It is also important for companies engaging in R&D activities to keep track of progress throughout the process so they can adjust course if necessary.
By monitoring progress closely, companies can make sure that resources are being used effectively and efficiently towards reaching desired goals while avoiding costly missteps or delays caused by unforeseen circumstances during development cycles.
Finally, it is essential for companies engaging in R&D activities to document all findings thoroughly so they can be shared with other departments within the organization. This ensures that valuable information isn’t lost over time but instead remains accessible whenever needed.
Types of R&D
R&D can be divided into two main categories: corporate and start-up.
Corporate R&D is typically done by large companies with dedicated departments staffed with engineers, industrial scientists, and other experts. This type of research often focuses on improving existing products or developing new ones.
Start-up R&D is more focused on creating innovative solutions to problems that don’t yet have a solution.
Start-ups are usually supported by venture capital firms through incubators or accelerators which help them bring their product to market and scale the business.
In addition to these two types of research, there are also public sector organizations such as universities and government agencies that conduct scientific research for the benefit of society at large. These organizations focus on research topics such as climate change, energy efficiency, and disease prevention instead of commercial products like corporations do.
Finally, there are also individual inventors who work independently in their own laboratories or workshops to develop inventions that could potentially revolutionize an industry or solve a problem no one else has been able to solve before.
Inventors often rely heavily on crowdfunding platforms like Kickstarter in order to finance their projects since they lack access to traditional sources of funding like venture capital firms or corporate sponsorships.
Regardless of what type of R&D you’re involved in – whether it’s corporate research for big companies or independent inventions – having access to reliable data sources is essential for making informed decisions about your project’s direction and progress over time.
That’s where Cypris comes in. We provide teams with a centralized platform so they can quickly gain insights from all their data sources without needing multiple tools or manual processes.
Why Invest in R&D?
Investing in research and development can bring many benefits to a business. Increased productivity, improved quality, and enhanced innovation are just some of the advantages that businesses can gain from investing in R&D.
Increased Productivity
Investing in R&D helps businesses become more efficient by allowing them to develop new processes or technologies that improve their operations. For example, using automation tools such as robotics or artificial intelligence can help reduce labor costs while increasing production speed and accuracy.
Additionally, investing in R&D may also lead to the discovery of new products or services which could further increase the profitability of a business.
Improved Quality
Investing in R&D gives you access to better resources, which allows you to produce higher-quality products and services. This includes utilizing advanced materials such as graphene or nanotechnology which offer superior performance compared to traditional materials used for manufacturing purposes.
Additionally, R&D teams may be able to identify potential defects early on during product development stages, thus preventing costly recalls due to faulty products.
Enhanced Innovation
Finally, investing in R&D encourages creativity within an organization, leading it toward innovative solutions. Companies that invest heavily in their own internal research initiatives often find themselves at the forefront of emerging trends within their respective industries.

(Source)
Challenges of Investing in R&D
Investing in R&D comes with its own set of challenges. High costs and risk are two of the most significant issues that companies face when investing in research and development.
Developing new products or services requires substantial financial resources, which can often lead to budget overruns if not managed properly.
Additionally, there is always an element of risk involved when launching a new product or service. Even after extensive testing and market analysis, there is no guarantee that the product will be successful.
Another challenge associated with investing in R&D is the long time-to-market. Even after extensive research and development efforts have been completed, it still takes time for the product or service to reach consumers. This process includes manufacturing, marketing campaigns, and distribution channels — all of which require additional resources and effort from the company.
Finally, measuring ROI on investments made in R&D projects can also be difficult due to various factors such as a lack of data points available for comparison purposes or difficulty predicting future trends accurately.
Companies need to develop effective strategies for tracking progress against goals set during project planning stages so they can measure their return on investment more effectively over time.
Why Invest in R&D With Cypris?
R&D teams must have the right tools and technologies to ensure success. Cypris is a research platform that provides centralized data sources for rapid time to insights, automated workflows for streamlined processes, and collaborative platforms for easier communication and decision-making.
Centralized Data Sources
With Cypris’s centralized data sources, R&D teams can quickly access all of their information from one place without having to search through multiple systems or documents. This helps them save time by reducing the need to manually enter data into different systems or compile reports from various sources.
Additionally, they can easily analyze trends across projects with real-time visualizations so they can make better decisions faster.
Automated Workflows
Automating tedious tasks such as reporting saves valuable time that could be spent on more productive activities like brainstorming new ideas or analyzing results. Cypris offers automated workflows that enable users to set up custom rules based on specific criteria so they don’t have to worry about manual entry errors or missed deadlines. These automated workflows help streamline processes so teams are able to focus on higher-value tasks instead of mundane ones.
Collaborative Platforms
Collaboration is key when it comes to successful innovation initiatives. However, traditional methods of communication often lead to delays in decision-making due lack of difficulty coordinating between multiple stakeholders spread out across different locations and departments. With its collaborative platform feature, Cypris enables team members to stay connected while tracking progress in real time, which leads to increased productivity and improved quality outcomes.
By leveraging these features offered by Cypris, businesses will be able to maximize their return on investment (ROI) while minimizing costs associated with investing in R&D.
Conclusion
Why invest in R&D?
The benefits of investing in R&D outweigh its challenges when done correctly. Setting clear goals and objectives, utilizing appropriate tools and technologies, developing an effective team structure and processes, tracking progress, measuring ROI accurately, and creating a culture of continuous improvement all play key roles in ensuring successful outcomes from any given project.
With the right strategies and tools like Cypris, companies can maximize their return on investment while minimizing risk. By leveraging data-driven insights to inform decisions and streamline processes, organizations can ensure that their investments in R&D will pay off in the long run.
Investing in research and development is essential for staying competitive, innovating faster, and driving greater ROI. Cypris provides an easy-to-use platform that centralizes data sources teams need into one place so they can get insights quickly.
With Cypris‘ help, you’ll be able to drive innovation faster than ever before! Try out our R&D solutions today – let us show you how your business can benefit from the power of research and development!
Categories Quick Innovation Insights
How Big Data Can Revolutionize Pharmaceutical R&D
What Are Qualifying Research Activities for R&D Tax Credit?
Webinars
.png)

Most IP organizations are making high-stakes capital allocation decisions with incomplete visibility – relying primarily on patent data as a proxy for innovation. That approach is not optimal. Patents alone cannot reveal technology trajectories, capital flows, or commercial viability.
A more effective model requires integrating patents with scientific literature, grant funding, market activity, and competitive intelligence. This means that for a complete picture, IP and R&D teams need infrastructure that connects fragmented data into a unified, decision-ready intelligence layer.
AI is accelerating that shift. The value is no longer simply in retrieving documents faster; it’s in extracting signal from noise. Modern AI systems can contextualize disparate datasets, identify patterns, and generate strategic narratives – transforming raw information into actionable insight.
Join us on Thursday, April 23, at 12 PM ET for a discussion on how unified AI platforms are redefining decision-making across IP and R&D teams. Moderated by Gene Quinn, panelists Marlene Valderrama and Amir Achourie will examine how integrating technical, scientific, and market data collapses traditional silos – enabling more aligned strategy, sharper investment decisions, and measurable business impact.
Register here: https://ipwatchdog.com/cypris-april-23-2026/
.png)
In this session, we break down how AI is reshaping the R&D lifecycle, from faster discovery to more informed decision-making. See how an intelligence layer approach enables teams to move beyond fragmented tools toward a unified, scalable system for innovation.
.png)
In this session, we explore how modern AI systems are reshaping knowledge management in R&D. From structuring internal data to unlocking external intelligence, see how leading teams are building scalable foundations that improve collaboration, efficiency, and long-term innovation outcomes.
.avif)


%20-%20Sustainable%20Packaging%20in%20Food%20%26%20Beverage.png)
%20-%20Next%20Generation%20Invisible%20Fishing%20Line.png)
%20-%20Noninvasive%20VNS.png)